Article
Amyloid-beta peptides 40 and 42 employ distinct molecular pathways for cell entry and…
medRxiv · 2022 · Wang, Z.; Sharda, N.; Omtri, R.; Li, L.; Kandimalla, K. K.
Key facts
| Title | Amyloid-beta peptides 40 and 42 employ distinct molecular pathways for cell entry and intracellular transit at the BBB endothelium |
|---|---|
| First author | Wang, Z.; Sharda, N.; Omtri, R.; Li, L.; Kandimalla, K. K. |
| Journal | medRxiv |
| Published | Nov 18, 2022 |
| DOI | 10.1101/2022.11.17.516996 |
| Devices mentioned | DEN000008, K022086, K103302, K810863 |
| Product codes mentioned | DBM, JCI, KIT, NDS, NJT, OOI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1